Target intelligence / Profile preview

Clostridioides difficile Toxin A receptor complex (TcdA receptor complex)

Target
TcdA receptor complex
Molecular classification
Receptor, Glycoprotein, Enzyme, Chaperone, Tumor necrosis factor receptor superfamily
01

Overview

The Intestinal epithelial toxin A receptor complex refers to the assembly of host cell surface molecules, such as sucrase-isomaltase (SI), glycoprotein 96 (gp96), and the nerve growth factor receptor (p75NTR), that mediate the binding and internalization of Clostridioides difficile Toxin A (TcdA) (Pothoulakis et al., 1996; Na et al., 2008; Yuan et al., 2015). TcdA is a potent enterotoxin and a primary virulence factor in C. difficile infections, causing significant mucosal damage, inflammation, and fluid secretion (Gerhard, 2017). The receptor complex facilitates the endocytosis of TcdA, which subsequently glucosylates host Rho-family GTPases, leading to the collapse of the actin cytoskeleton and disruption of the intestinal barrier (Voth & Ballard, 2005). This molecular cascade results in the clinical symptoms of pseudomembranous colitis and severe diarrhea (Kelly & LaMont, 2008). Therapeutic strategies have focused on neutralizing TcdA using monoclonal antibodies like actoxumab to prevent its association with these receptors (Lowy et al., 2010). Although actoxumab was developed to target this interaction, clinical success has been more pronounced with therapies targeting Toxin B, reflecting the complex synergy between the two toxins in human disease (Wilcox et al., 2017).

Other names
TcdA receptorC. difficile Toxin A receptorSucrase-isomaltase (TcdA receptor)gp96 (TcdA receptor)HSP90B1 (TcdA receptor)p75NTR (TcdA receptor)NGFR (TcdA receptor)
02

Mechanism of action

Neutralization of Toxin A to prevent its interaction with host cell surface receptors and subsequent internalization into enterocytes.

03

Biological functions

Cellular entry of toxinsEndocytosisCarbohydrate metabolismProtein foldingSignal transductionApoptosis induction
04

Disease associations

InfectionClostridioides difficile-associated diarrhea (CDAD)Pseudomembranous colitisInflammationGastrointestinal disease
05

Safety considerations

Recurrence of C. difficile infectionPotential for antibody-dependent enhancementImmunogenicity of monoclonal antibodiesAlteration of the gut microbiome
06

Interacting drugs

Actoxumab

1 more in the full profile.

07

Biomarkers

C. difficile Toxin A (TcdA) in stoolGlutamate dehydrogenase (GDH)Fecal calprotectinTcdA-specific IgG titers

Beyond the preview

Go deeper on Clostridioides difficile Toxin A receptor complex (TcdA receptor complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile Toxin A receptor complex (TcdA receptor complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call